Table 1 Characteristics of patients according to the HPV integration status
Characteristics |  | HPV integration (n = 10) | HPV non-integration (n = 63) | p |
|---|---|---|---|---|
Age |  | 37.80 ± 9.80 | 40.41 ± 10.51 | 0.846 |
HPV vaccination, n [%] | Yes | 0 (0.0) | 12(19.0) | / |
| Â | No | 10(100.0) | 51(81.0) | Â |
Reproductive history, n [%] | Yes | 5(50.0) | 48(76.2) | 0.085 |
| Â | No | 5(50.0) | 15(23.8) | Â |
Reproductive needs, n [%] | Yes | 6(60.0) | 24(38.1) | 0.191 |
| Â | No | 4(40.0) | 39(61.9) | Â |
Endocervical gland invasion, n [%] | No invasion | 6(60.0) | 47(74.6) | 0.278 |
| Â | Invasion | 4(40.0) | 16(25.4) | Â |
Margin status, n [%] | Negative | 8(80.0) | 58(92.1) | 0.229 |
Positive | 2(20.0) | 5(7.9) | Â | |
Post-operative type of HPV infection, n [%] | Single infection | 6(60.0) | 49(77.8) | 0.226 |
Multiple infections | 4(40.0) | 14(22.2) | Â | |
Post-operative HPV genotype, n [%] | HPV-16/18(+) | 3(30.0) | 23(36.5) | 0.493§ |
| Â | Non-16/18 HPV(+) | 7(70.0) | 40(63.5) | Â |
Residual/recurrent diseases at 1 year, n [%] | No Residual/ recurrent CIN | 6(60.0) | 39(88.6) | 0.028 |
Residual/recurrent CIN | 4(40.0) | 5(11.4) | Â |